Browsing: HIV

rol

February 14, 2020 was the day that the first case of Covid-19 was reported in the Africa Continent, and this was in Egypt, today almost every country in the continent has registered Covid-19 cases with the WHO. With Africans nations embracing the new normal and reportage indicating declining trend in new cases across much of the region, seven countries, including Benin, Eritrea, Eswatini, Liberia, Nigeria, Sierra Leone and South Africa are showing
an increase of more than 20% in cases.

A slight increase in deaths was also reported. South Africa has seen an increase in weekly cases for the second consecutive week. Even with a declining trend across the African region, the high number of cases reported globally still pose a risk for the region. Additionally, three countries have very high rates of community transmission and are of serious concern.

Testing in most of the African countries has seen Multidimensional …

Generic drug manufacturers in Africa race to meet demand for key HIV drug

For Jacqueline Wambui, a resident of Nairobi, living with the HIV virus has been a challenge. As an activist and a person living with the virus, she has gone through several treatment regimens as she manages her condition. However, none seem to have worked better than the new approved WHO recommended medication.

The World Health Organization recommends dolutegravir (DTG)-based treatment as the preferred first-line regimen for people living with HIV.

Jacque currently runs the Advocacy and Communications function at the network. Her educational background is in HIV counseling and training.

She is an HIV positive activist with a special interest in sexual and reproductive health for young HIV positive women and girls and advocating for their rights. Jacqueline was put on several different antiretroviral regimens, including d4T (stavudine), nevirapine and efavirenz before being switched to TLD (tenofovir/lamivudine/dolutegravir).

“The main differences dolutegravir (DTG) has made is that it has much fewer …